Labome logo
home > human > MEK5 inhibitor/activator/substrate/reporter | 3 products cited in the literature; 3 total from 2 suppliers
Your Filters
product
  • 1213/1
    Tocris Bioscience
    catalog: 1213/1
    citations: 109

    Cat.No. 1213 - PD 98059 C16H13NO3 CAS No. 167869-21-8
    quantity: 1 mg (also 10 mg, 50 mg)
    price: 100 USD
    to the supplier
  • 4842/10
    Tocris Bioscience
    catalog: 4842/10
    citations: 5

    Cat.No. 4842 - BIX 02189 C27H28N4O2 CAS No. 1265916-41-3
    quantity: 10 mg
    price: 278 USD
    to the supplier
  • PD 98059
    Alomone Labs
    catalog: P-260
    citations: 1


    Alomone Labs PD 98059 inhibits P42/44 MAPK (ERK) phosphorylation via MEK in C6 glioma cells. - Cells were grown to 70% confluence and serum starved for 1.5 h. The cells were then incubated for 2 h with various concentrations ofPD 98059(#P-260) and stimulated with 7 ng/ml PDGF-AA. Cell proteins were resolved by SDS-PAGE and probed with anti-phospho-P42/44 (upper panel) and with anti-P42/44 (lower panel) antibodies. Inhibition of P42/44 phosphorylation by PD 98059 was dose-dependent.
    quantity:
    price:
    to the supplier
gene information - human MEK5
    • synonym:HsT17454; MAPKK5; MEK5; PRKMK5
    • description:mitogen-activated protein kinase kinase 5
do you know?
  • we limit the listing of re-branded antibodies to provide our visitors with accurate information and the best experience
  • we manually curate antibody information from the literature to obtain a comprehensive set of well-validated antibodies.
  • we limit citation information for polyclonal antibodies to articles published within the last 5 years because the supply of a particular polyclonal antibody preparation is limited.
product type
  • MEK5 chemical
  • MEK5 antibody
  • MEK5 gene knockdown
  • MEK5 cDNA
  • MEK5 protein
  • MEK5 other
related gene
  • ERK5
  • BTBD9
  • MEIS1
  • STAT3
  • MEKK3
  • MAP3K2
  • SKOR1
  • ENO1
  • FLT3
  • MEF2C
linkout
  • ncbi
  • review
questions and comments

 
Labome.com © 2025 All Rights Reserved
last updated:2025-08-31